By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Breaking US News – USA Business MediaBreaking US News – USA Business MediaBreaking US News – USA Business Media
  • Home
  • USA
  • World
  • Business
    • CEO
    • Entrepreneur
    • Founder
    • Journalist
    • Realtor
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness Trainer
  • Cryptocurrency
  • Entertainment
  • Technology
Font ResizerAa
Breaking US News – USA Business MediaBreaking US News – USA Business Media
Font ResizerAa
  • Home
  • USA
  • World
  • Business
  • Health
  • Sports
  • Cryptocurrency
  • Entertainment
  • Technology
Search
  • Home
  • USA
  • World
  • Business
    • CEO
    • Entrepreneur
    • Founder
    • Journalist
    • Realtor
  • Health
    • Doctor
    • Plastic Surgeon
    • Beauty Cosmetics
  • Sports
    • Athlete
    • Coach
    • Fitness Trainer
  • Cryptocurrency
  • Entertainment
  • Technology
Follow US
Home » Blog » Trump Administration Continues Defense of Corporate Transparency Act, Indicates FinCEN’s Flexibility On Deadlines And Scope
USA

Trump Administration Continues Defense of Corporate Transparency Act, Indicates FinCEN’s Flexibility On Deadlines And Scope

Jessica Brown
By Jessica Brown
Share
3 Min Read
SHARE

As of our last client update on the Corporate Transparency Act (CTA) litigation (see CTA client alert), the U.S. Supreme Court, in an 8-1 ruling, lifted a nationwide injunction issued by a Texas trial court in Texas Top Cop Shop v. Bondi that had blocked CTA enforcement, but another nationwide injunction issued by another Texas trial court in Smith v. United States Department of the Treasury continued to stall CTA implementation. Now, the new Trump Administration, in its first formal actions related to the CTA litigations, (i) on February 5, filed a notice of appeal and motion to stay the injunction in Smith, and (ii) on February 7, filed a brief supporting the constitutionality of the CTA in Texas Top Cop Shop. Given the Supreme Court’s decision in Texas Top Cop Shop to lift the injunction against CTA enforcement, we believe the government’s effort to stay the injunction in Smith is likely to succeed.

These steps by the Trump Administration are notable for two reasons.

First, while new presidential administrations routinely continue to support in court the constitutionality of laws passed prior to the new president taking office, that is not always the case, and it was uncertain where the CTA would fall under the Trump Administration. While no guarantee of permanency, for now, the Department of Justice continues to defend the constitutionality of the law and seek its prompt implementation.

Second, in the motion in Smith, the Administration provided its first indication of how it is thinking about CTA implementation: “As a matter of policy, Treasury continues to assess the potential burden of the Final Rule. If this Court grants the stay, [the U.S. Financial Crimes Enforcement Network (FinCEN)] intends to announce that it will extend the compliance deadline for thirty days. During that period, FinCEN intends to assess its potential options to prioritize reporting for those entities that pose the most significant national security risks while providing relief to lower-risk entities and, if warranted, amending the Final Rule.” As always in this litigation chronicle, these developments leave CTA reporting companies facing considerable uncertainty. The current litigating position or policy considerations of the Administration may change, many of the terms in the Administration’s policy statement above remain undefined, and the courts’ decisions remain pending.

Finally, we note that oral argument in Texas Top Cop Shop, originally scheduled for March 25, 2025, is now calendared for April 1, 2025, before the Fifth Circuit. If you have any questions concerning this memorandum, please feel free to contact your regular contacts at the firm.

Share This Article
Facebook Copy Link Print

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Rahul Yadav Indian Entrepreneur | India’s Mastermind of IT Innovation

In a time when technology reshapes every aspect of life and business,…

Apple’s ‘Friday Night Baseball’ is back on March 28 with a World Series documentary in tow

Apple's offered Major League Baseball games through the Apple TV app since…

10 Benefits of Forex Hedging Most Traders Don’t Know About

Hedging is possibly the most misunderstood trading method in the world. It's…

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.
Sign Up for Free

You Might Also Like

USA

Establishment Darling Lisa Murkowski Says She Is ‘Anxious’ About Using Her Voice: ‘We Are All Afraid’

By Jessica Brown
USA

Sec. of the Navy Announces Kristina Wong as Director of Comms

By Jessica Brown
USA

Virginia Gov. Glenn Youngkin Joins Feds to Detain 521 Violent Illegals

By Jessica Brown
USA

Swiss Pharma Giant Roche to Invest $50+ Billion in U.S.

By Jessica Brown
Breaking US News – USA Business Media
USA
  • USA
  • World
  • Technology
  • Cryptocurrency
Business
  • CEO
  • Founder
  • Journalist
  • Entrepreneur
  • Technology
Health
  • Doctor
  • Beauty Cosmetics
  • Plastic Surgeon
Sports
  • Coach
  • Fitness Trainer
  • Entertainment

© 2017-2025 usabusinessmedia. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?